• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

5-Pyrimidinecarboxamide, 2-methyl- (7CI,8CI)

5-Pyrimidinecarboxamide, 2-methyl- (7CI,8CI), also known as CAS No. 5194-33-2, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidine derivatives, which have been extensively studied due to their diverse biological activities and potential therapeutic applications. The structure of 5-Pyrimidinecarboxamide, 2-methyl- consists of a pyrimidine ring with a methyl group at position 2 and a carboxamide group at position 5. This unique arrangement contributes to its distinct chemical properties and biological functions.

Recent studies have highlighted the importance of pyrimidine derivatives in drug discovery, particularly in the development of anticancer agents. The 5-Pyrimidinecarboxamide, 2-methyl- structure has been shown to exhibit promising antiproliferative activity against various cancer cell lines. Researchers have utilized advanced computational methods, such as molecular docking and QSAR modeling, to understand the binding interactions of this compound with key oncogenic targets. These findings underscore its potential as a lead compound for further optimization in cancer therapy.

In addition to its anticancer properties, 5-Pyrimidinecarboxamide, 2-methyl- has also been investigated for its role in modulating cellular signaling pathways. For instance, studies have demonstrated its ability to inhibit specific kinases involved in cell proliferation and survival. This makes it a valuable tool in understanding the molecular mechanisms underlying various diseases, including neurodegenerative disorders and inflammatory conditions.

The synthesis of 5-Pyrimidinecarboxamide, 2-methyl- involves a multi-step process that typically begins with the preparation of the pyrimidine ring followed by functionalization at specific positions. Recent advancements in synthetic chemistry have enabled more efficient and scalable methods for producing this compound. For example, the use of microwave-assisted synthesis has significantly reduced reaction times while maintaining high yields.

From an analytical standpoint, CAS No. 5194-33-2 has been characterized using various spectroscopic techniques such as NMR and IR spectroscopy. These analyses provide critical insights into the compound's molecular structure and purity. Furthermore, mass spectrometry has been employed to confirm its molecular formula and detect any impurities that may arise during synthesis.

Looking ahead, the continued exploration of 5-Pyrimidinecarboxamide, 2-methyl- is expected to yield further insights into its therapeutic potential. Collaborative efforts between academic institutions and pharmaceutical companies are paving the way for preclinical studies aimed at evaluating its safety and efficacy in vivo. Such research is crucial for translating laboratory findings into clinical applications that can benefit patients worldwide.

In conclusion, 5-Pyrimidinecarboxamide, 2-methyl- (7CI,8CI) or CAS No. 5194-33-2 stands as a testament to the ongoing advancements in chemical research. Its unique structure, coupled with emerging scientific discoveries, positions it as a promising candidate in the development of innovative therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)